Michael J Quist
Overview
Explore the profile of Michael J Quist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
2591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su S, You S, Wang Y, Tamukong P, Quist M, Grasso C, et al.
Cancer Lett
. 2022 Dec;
555:216034.
PMID: 36509363
Antitumor immunity requires lymphocytes to localize to the tumor. Prostate cancers (PCs) are immunologically cold and tend to lack T-cell infiltration. Most advanced PCs are insensitive to PD1 blockade therapies....
2.
Abril-Rodriguez G, Torrejon D, Liu W, Zaretsky J, Nowicki T, Tsoi J, et al.
Nat Cancer
. 2022 Feb;
1(2):264.
PMID: 35122015
No abstract available.
3.
Abril-Rodriguez G, Torrejon D, Liu W, Zaretsky J, Nowicki T, Tsoi J, et al.
Nat Cancer
. 2021 Aug;
1(1):46-58.
PMID: 34368780
Lack of tumor infiltration by immune cells is the main mechanism of primary resistance to programmed cell death protein 1 (PD-1) blockade therapies for cancer. It has been postulated that...
4.
Zaidi S, Harrison T, Phipps A, Steinfelder R, Trinh Q, Qu C, et al.
Nat Commun
. 2020 Jul;
11(1):3644.
PMID: 32686686
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational profile, we conduct targeted sequencing of 205 genes for 2,105 CRC cases with survival data. Our data shows...
5.
Berlow N, Grasso C, Quist M, Cheng M, Gandour-Edwards R, Hernandez B, et al.
Sarcoma
. 2020 Jun;
2020:6312480.
PMID: 32565715
Nonrhabdomyosarcoma soft-tissue sarcomas (STSs) are a class of 50+ cancers arising in muscle and soft tissues of children, adolescents, and adults. Rarity of each subtype often precludes subtype-specific preclinical research,...
6.
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential
Miller E, You S, Cadaneanu R, Kim M, Yoon J, Liu S, et al.
BMC Cancer
. 2020 May;
20(1):398.
PMID: 32380981
Background: Metastatic prostate cancer (PC) is highly lethal. The ability to identify primary tumors capable of dissemination is an unmet need in the quest to understand lethal biology and improve...
7.
Berlow N, Rikhi R, Geltzeiler M, Abraham J, Svalina M, Davis L, et al.
BMC Cancer
. 2019 Jun;
19(1):593.
PMID: 31208434
Background: Cancer patients with advanced disease routinely exhaust available clinical regimens and lack actionable genomic medicine results, leaving a large patient population without effective treatments options when their disease inevitably...
8.
Berlow N, Svalina M, Quist M, Settelmeyer T, Zherebitskiy V, Kogiso M, et al.
PLoS One
. 2018 Apr;
13(4):e0193565.
PMID: 29621254
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal childhood cancer of the brain. Despite the introduction of conventional chemotherapy and radiotherapy, improvements in survival have been marginal and long-term...
9.
Hovelson D, Liu C, Wang Y, Kang Q, Henderson J, Gursky A, et al.
Oncotarget
. 2017 Nov;
8(52):89848-89866.
PMID: 29163793
Current cell-free DNA (cfDNA) next generation sequencing (NGS) precision oncology workflows are typically limited to targeted and/or disease-specific applications. In advanced cancer, disease burden and cfDNA tumor content are often...
10.
Stires H, Heckler M, Fu X, Li Z, Grasso C, Quist M, et al.
Mol Cell Endocrinol
. 2017 Sep;
471:105-117.
PMID: 28935545
Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathological, and molecular features that distinguish it from the more common invasive ductal carcinoma (IDC). Mounting evidence suggests...